Search research articles
Contact Us
Filters
Showing results (61-70 of 207) with videos related to
Page
of 21
Sort By:
Nature Reviews. Drug Discovery
|
May 18, 2021
Kinase drug discovery 20 years after imatinib: progress and future directions
Philip Cohen, Darren Cross, Pasi A Jänne
FEBS Letters
|
August 12, 2004
Signalling pathways involved in multisite phosphorylation of the transcription factor ATF-2
Simon Morton, Roger J Davis, Philip Cohen
Annals of the Rheumatic Diseases
|
January 19, 2024
Morris Ziff
Philip Cohen, David Ziff, Peter E Lipsky
The Biochemical Journal
|
July 18, 2002
A non-radioactive method for the assay of many serine/threonine-specific protein kinases
Heike Ross, Christopher G Armstrong, Philip Cohen
Nature Reviews. Drug Discovery
|
April 2, 2022
Kinase drug discovery 20 years after imatinib
Philip Cohen, Darren Cross, Pasi A Jänne
The Biochemical Journal
|
May 17, 2017
Interleukin-1 and TRAF6-dependent activation of TAK1 in the absence of TAB2 and TAB3
Jiazhen Zhang, Thomas Macartney, Mark Peggie, et al.
The Journal of Biological Chemistry
|
October 15, 2003
15-Deoxy-Delta12,14-prostaglandin J2 regulates endogenous Cot MAPK kinase kinase 1 activity induced by lipopolysaccharide
Matilde Caivano, Cristina Rodriguez, Philip Cohen, et al.
The Biochemical Journal
|
January 22, 2003
The specificities of protein kinase inhibitors: an update
Jenny Bain, Hilary McLauchlan, Matthew Elliott, et al.
FEBS Letters
|
March 1, 2008
Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma
Simon Morton, Luke Hesson, Mark Peggie, et al.
Molecular and Cellular Biology
|
January 9, 2008
Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinase
Mark Windheim, Margaret Stafford, Mark Peggie, et al.
Page
of 21
Search research articles
Search
Showing results (61-70 of 207) with videos related to
Sort By:
Page
of 21
Nature Reviews. Drug Discovery
|
May 18, 2021
Kinase drug discovery 20 years after imatinib: progress and future directions
Philip Cohen, Darren Cross, Pasi A Jänne
FEBS Letters
|
August 12, 2004
Signalling pathways involved in multisite phosphorylation of the transcription factor ATF-2
Simon Morton, Roger J Davis, Philip Cohen
Annals of the Rheumatic Diseases
|
January 19, 2024
Morris Ziff
Philip Cohen, David Ziff, Peter E Lipsky
The Biochemical Journal
|
July 18, 2002
A non-radioactive method for the assay of many serine/threonine-specific protein kinases
Heike Ross, Christopher G Armstrong, Philip Cohen
Nature Reviews. Drug Discovery
|
April 2, 2022
Kinase drug discovery 20 years after imatinib
Philip Cohen, Darren Cross, Pasi A Jänne
The Biochemical Journal
|
May 17, 2017
Interleukin-1 and TRAF6-dependent activation of TAK1 in the absence of TAB2 and TAB3
Jiazhen Zhang, Thomas Macartney, Mark Peggie, et al.
The Journal of Biological Chemistry
|
October 15, 2003
15-Deoxy-Delta12,14-prostaglandin J2 regulates endogenous Cot MAPK kinase kinase 1 activity induced by lipopolysaccharide
Matilde Caivano, Cristina Rodriguez, Philip Cohen, et al.
The Biochemical Journal
|
January 22, 2003
The specificities of protein kinase inhibitors: an update
Jenny Bain, Hilary McLauchlan, Matthew Elliott, et al.
FEBS Letters
|
March 1, 2008
Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma
Simon Morton, Luke Hesson, Mark Peggie, et al.
Molecular and Cellular Biology
|
January 9, 2008
Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinase
Mark Windheim, Margaret Stafford, Mark Peggie, et al.
Page
of 21